TabletsMRP Under Process
Official PMBI MRP is being updated for catalog code 1703.
Locate Jan Aushadhi KendraClinical Overview
Metadoxine (500mg), Silymarin (140mg), and L-Ornithine L-Aspartate (150mg) Tablets is a hepatoprotective formulation. Silymarin (milk thistle flavonolignan) stabilizes hepatocyte plasma membranes, inhibits lipid peroxidation, and stimulates ribosomal RNA synthesis to accelerate liver regeneration. Metadoxine accelerates ethanol and acetaldehyde clearance, restoring cellular ATP and glutathione. LOLA enhances ammonia detoxification via the hepatic urea cycle. Indicated for alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD/NASH), acute and chronic hepatitis, and early liver cirrhosis.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally 1 tablet twice or thrice daily after meals with a glass of water. Swallow whole. Duration: 1 to 3 months as directed by hepatologist.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Mild gastrointestinal upset, nausea, loose stools, headache. Rare/Severe: Mild allergic skin reactions. Safe hepatoprotective profile.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in patients with hypersensitivity to milk thistle plants (Asteraceae family) or severe renal failure. Does not replace alcohol cessation in alcoholic liver disease.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or gastrointestinal treatment recommendations. Always consult a registered gastroenterologist or qualified medical practitioner before initiating, altering, or discontinuing any gastrointestinal medication or digestive therapy.
L- Ornithine L-Aspartate Infusion 5gm per 10ml
L- Ornithine L-Aspartate Infusion 5gm per 10ml is an established pharmaceutical and nutritional agent in the Vitamins, Minerals & Nutrition category on the PMBI National Formulary. Formulated to provide micronutrient replenishment, metabolic support, or nutritional therapy according to verified pharmacopoeial standards.
L-Ornithine L-Aspartate 150mg + Pancreatin 100mg Tablets
L-Ornithine L-Aspartate (150mg) and Pancreatin (100mg) Tablets combines an ammonia-detoxifying metabolic amino acid with digestive pancreatic enzymes. LOLA stimulates urea cycle carbamoyl phosphate synthetase in hepatocytes and glutamine synthesis in skeletal muscle, clearing neurotoxic ammonia. Pancreatin supplies amylase, lipase, and protease to assist nutrient breakdown in patients with compromised digestion. Indicated for hepatic dysfunction, fatty liver, subclinical hepatic encephalopathy, and digestive insufficiency associated with liver cirrhosis.
Silymarin Tablet 140 mg
Silymarin Tablets (140mg) is a purified extract of flavonolignans (primarily silybin) from milk thistle (Silybum marianum) on the PMBI formulary. It acts as a potent antioxidant, scavenges reactive oxygen species, prevents lipid peroxidation of cell membranes, stimulates nucleolar polymerase A to enhance ribosomal protein synthesis, and exerts antifibrotic effects by suppressing hepatic stellate cell activation. Indicated as supportive therapy in chronic inflammatory liver disease, non-alcoholic fatty liver disease (NAFLD), and toxin/alcohol-induced liver injury.
L-Ornithine L-Aspartate 150mg + Pancreatin 100mg Tablets
L-Ornithine L-Aspartate (150mg) and Pancreatin (100mg) Tablets combines an ammonia-detoxifying metabolic amino acid with digestive pancreatic enzymes. LOLA stimulates urea cycle carbamoyl phosphate synthetase in hepatocytes and glutamine synthesis in skeletal muscle, clearing neurotoxic ammonia. Pancreatin supplies amylase, lipase, and protease to assist nutrient breakdown in patients with compromised digestion. Indicated for hepatic dysfunction, fatty liver, subclinical hepatic encephalopathy, and digestive insufficiency associated with liver cirrhosis.